Tomohiro Tanaka

Sendai, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 125 publications

Epitope Mapping of Anti-mouse ACKR4 Monoclonal Antibodies Developed by N-Terminal Peptide Immunization.

Epitope Mapping of Anti-mouse ACKR4 Monoclonal Antibodies Developed by N-Terminal Peptide Immunization.

Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy

Published: June 16, 2026

Establishment of a Novel Anti-EphA4 Monoclonal Antibody, Ea4Mab-3, for Versatile Applications.

Establishment of a Novel Anti-EphA4 Monoclonal Antibody, Ea4Mab-3, for Versatile Applications.

Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy

Published: May 23, 2026

A Fatal Case of AIDS Complicated by Kaposi's Sarcoma-associated Inflammatory Cytokine Syndrome (KICS).

A Fatal Case of AIDS Complicated by Kaposi's Sarcoma-associated Inflammatory Cytokine Syndrome (KICS).

Journal: Internal medicine (Tokyo, Japan)

Published: May 06, 2026

Cx2Mab-5: A Novel Anti-Mouse CXCR2 Monoclonal Antibody Developed by N-Terminus Peptide Immunization for Multiple Applications.

Cx2Mab-5: A Novel Anti-Mouse CXCR2 Monoclonal Antibody Developed by N-Terminus Peptide Immunization for Multiple Applications.

Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy

Published: February 19, 2026

Antitumor Activities of Chimeric Anti-EphA2 Antibodies in Xenograft Models of Breast, Pancreatic, and Colorectal Cancers.

Antitumor Activities of Chimeric Anti-EphA2 Antibodies in Xenograft Models of Breast, Pancreatic, and Colorectal Cancers.

Journal: International journal of molecular sciences

Published: February 05, 2026

Therapeutic Potential of an Anti-CD44v6 Monoclonal Antibody in Xenograft Models of Colorectal and Gastric Cancer.

Therapeutic Potential of an Anti-CD44v6 Monoclonal Antibody in Xenograft Models of Colorectal and Gastric Cancer.

Journal: Cells

Published: October 15, 2025

A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (humPcMab-60) Demonstrated Antitumor Efficacy in Pancreatic and Colorectal Cancer Xenograft Models.

A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (humPcMab-60) Demonstrated Antitumor Efficacy in Pancreatic and Colorectal Cancer Xenograft Models.

Journal: Antibodies (Basel, Switzerland)

Published: June 30, 2025

Design and Evaluation of Eb4Mab-7-mG2a: A Dual-Action Anti-EphB4 Monoclonal Antibody for Targeted Breast Cancer Therapy.

Design and Evaluation of Eb4Mab-7-mG2a: A Dual-Action Anti-EphB4 Monoclonal Antibody for Targeted Breast Cancer Therapy.

Journal: Cancer science

Published: June 26, 2025

Development of a Novel Anti-human EphA1 Monoclonal Antibody, Ea1Mab-30, for Multiple Applications.

Development of a Novel Anti-human EphA1 Monoclonal Antibody, Ea1Mab-30, for Multiple Applications.

Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy

Published: June 25, 2025

Epitope analysis of an anti-mouse CCR1 monoclonal antibody S15040E using flow cytometry.

Epitope analysis of an anti-mouse CCR1 monoclonal antibody S15040E using flow cytometry.

Journal: Biochemistry and biophysics reports

Published: April 18, 2025

PMab-322: a novel anti-hippopotamus podoplanin monoclonal antibody for multiple applications.

PMab-322: a novel anti-hippopotamus podoplanin monoclonal antibody for multiple applications.

Journal: Biochemistry and biophysics reports

Published: April 04, 2025

Development of an anti-CDH15/M-cadherin monoclonal antibody Ca15Mab-1 for flow cytometry, immunoblotting, and immunohistochemistry.

Development of an anti-CDH15/M-cadherin monoclonal antibody Ca15Mab-1 for flow cytometry, immunoblotting, and immunohistochemistry.

Journal: Biochemistry and biophysics reports

Published: April 03, 2025

Showing 1-12 of 125

Last Updated: 09/26/2026